MIGUEL
MINGUEZ PEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublications in collaboration with researchers from Complexo Hospitalario Universitario de Santiago (6)
2022
-
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study
Alimentary pharmacology & therapeutics, Vol. 55, Núm. 11, pp. 1402-1413
2021
-
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Journal of Crohn's and Colitis, Vol. 15, Núm. 11, pp. 1846-1851
2020
-
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis
Gastroenterologia y Hepatologia, Vol. 43, Núm. 2, pp. 97-105
2019
-
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
Therapeutic Advances in Gastroenterology, Vol. 12
2017
-
Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study
Inflammatory Bowel Diseases, Vol. 23, Núm. 10, pp. 1840-1846
2016
-
Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project
Inflammatory Bowel Diseases, Vol. 22, Núm. 3, pp. 583-589